Setup News Ticker
Searching for 'variant COVID'. (Return) News - Top StoriesJan 27, 2022
Monoclonal antibodies were 'doing nothing' against omicron. That's why FDA pulled its authorization.
Monoclonal antibodies from drug-makers Regeneron and Eli Lilly have proven ineffective against the omicron variant of COVID-19.      
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2022 CEOExpress Company LLC